Genes regulating the sensitivity of solid tumor cell lines to cytotoxic agents: A literature review

Japanese Journal of Clinical Oncology

Volumn 37, Issue 5, 2007, Pages 329-336

  Sekine, Ikuo ^a   Minna, John D ^b   Nishio, Kazuto ^c   Saijo, Nagahiro ^d   Tamura, Tomohide ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Chemotherapy; Drug resistance; Sensitivity; Solid tumor

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; BREAST CANCER RESISTANCE PROTEIN; CAPECITABINE; CARRIER PROTEIN; CISPLATIN; DAUNORUBICIN; DOXIFLURIDINE; DOXORUBICIN; ESTRAMUSTINE; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; GLUTATHIONE TRANSFERASE P1; HYDROXYUREA; IRINOTECAN; LUNG RESISTANCE PROTEIN; METALLOTHIONEIN; METHOTREXATE; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; PROTEIN BCL 2; PROTEIN P53; THYMIDYLATE SYNTHASE; TOPOTECAN; TRANSCRIPTION FACTOR; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

APOPTOSIS; CANCER CELL CULTURE; CELL ADHESION; CELL CYCLE REGULATION; CELL SURVIVAL; CHEMOSENSITIVITY; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; DRUG RESPONSE; DRUG SENSITIVITY; DRUG TARGETING; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL LITERATURE; MEDLINE; MITOGENESIS; PHARMACOGENETICS; PREDICTION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DNA DAMAGE; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; TRANSFECTION;

EID: 34547915994     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym035     Document Type: Review

References (7)

1. Sekine I, Saijo N. Novel combination chemotherapy in the treatment of non-small cell lung cancer. Expert Opin Pharmacother 2000;1:1131-61.
2. Sekine I, Minna JD, Nishio Y, Tamura T, Saijo N. A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with lung cancer. J Thorac Oncol 2006;1:31-37.
3. Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC, Kaelin WG, Jr. Chemosensitivity link to p73 function. Cancer Cell 2003;3:403-10.
4. Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, et al. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell 2003;3:387-402.
5. Mariadason JM, Arango D, Shi Q, Wilson AJ, Comer GA, Nicholas C, et al. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res 2003;63:8791-812.
6. Chang GC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Elledge R, et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 2003;362:362-9.
7. Kikuch T, Daigo Y, Katagiri T, Tsunoda T, Okada K, Kakjuchi S, et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-nodc metastasis and sensitivity to anti-cancer drugs. Oncogene 2003;22:2192-205.